J.P. Morgan Sticks to Their Buy Rating for Boston Scientific (BSX)
I'm PortAI, I can summarize articles.
J.P. Morgan's Robbie Marcus reiterated a Buy rating for Boston Scientific, with shares closing at $96.11. Marcus, a 4-star analyst, has an average return of 8.3% and a 51.18% success rate. The analyst consensus suggests a Strong Buy for Boston Scientific, with a $126.35 average price target, indicating a 31.46% upside. Truist Financial also maintained a Buy rating with a $120.00 price target.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments